Discover millions of ebooks, audiobooks, and so much more with a free trial

Only $11.99/month after trial. Cancel anytime.

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy
Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy
Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy
Ebook1,057 pages8 hours

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

Rating: 0 out of 5 stars

()

Read preview

About this ebook

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy discusses recently developed treatments based on molecular targets which are genetically altered in cancer cells and are essential for tumor development and survival. Considerable research effort has been devoted to the development of targeted drugs that inhibit the action of pathogenic kinases, and clinical studies performed so far have validated the positive effects of kinase inhibitors for cancer treatment. Each chapter discusses a molecular target, such as ALK2, ATR, CK, Src-Abl, EGFR, Fyn-Blk-Lyn, IGFs, and PAK1.

The book's chapters are written by experts who actively work on the targets to help readers fully understand how they can be used. This is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of novel cancer therapies based on molecular targets.

  • Discusses recently discovered molecular targets for cancer therapy
  • Brings updated literature of heterocyclic compounds, an important construction motif for the development of new anticancer drugs
  • Encompasses comprehensive compilation of recently introduced anticancer drugs in the market and their health outcomes and pharmacoeconomics
LanguageEnglish
Release dateApr 10, 2024
ISBN9780323996327
Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

Related to Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

Related ebooks

Enterprise Applications For You

View More

Related articles

Reviews for Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

Rating: 0 out of 5 stars
0 ratings

0 ratings0 reviews

What did you think?

Tap to rate

Review must be at least 10 words

    Book preview

    Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy - Vivek Asati

    !fbook_preview_excerpt.html}rȵ>dA\*VJ]n;7dD h Rr8p0pZΝ{=fm"K.b_ ^x"z/K/̏=DȥzQ\Ͻ?m?2O("DʻɃջ*w"wQ}r Oz7Cq9xvbIz$/,WQh%2.x\)7fy &f|?eiv{o~n:³o^lr(o'w /­1 \n`jg6i?y;o[]{{/Kc LlWz-3?MpEJ=o(ѭ)* 7rVH{o ?0̓:rXh0AaXxn慂Hm&oX$". )N3Z4\\IH4.K# /eGe-xi!9JT8=F07$1MB9"}ZvzjDezŷOGLi%c4/UJWZÛ.j)V-[һ|%!dyt_zo>4BJ‚X/d%\@ -Qa /]8oY-ovzy,-p% ȓ2wq煃0%uF]_g,6ATysP_"cT}GuDK ?nsn?p]Lng/.kuu_=D]`kO) Umρr y[eͷ7gV +Nj`@J]зWWN6W+Ȍ d %ڹyOe#RnI kʫ rzMW <80K_^"7*/ :j *+-HwpB5c0$K?pPbc]ʖwjt7ɶ)- wp[% xAwJqȠ#j[<-!Q.Е̖[Xor+\m,џ0Bn^ Oq{~.@z5 q:ޛW7xwΑx鰣pmVó%{xIB:@xEޓǗ>')L=h GU7F9 Z`䦇%}|RDawQ&`zy83Zp4:!Ԉ.~/v{Kjj``aT ~h2 @ċ5@` };4vp^e1]y݉UL}*ZXz &?ԧAF-Li4fܹئv]B BOT:4Z"5upb7$c4ioG:GO9E)S>1xy4\ЭAEC@;{'V~/z[mG̔]%cE{>z,7?kz`XD(c3+,ˏ+,Oq, l]GF}Z%ol½}X^+oqY2_A < o(,`!oqcآ -,kѿS~~WDzGD =@+ΖO H\duCҟW}2l?x;)D$mRy6{o)Vm,-fcT]$h cRw @ Aa'*ǵQ&nw ^mtU -Wl) _K4rۜ" "Z()|;\=($zm83Pk̙X dٷ,%r5<\hadA:aQڀ%lچ1ALz|v(%T!(c|Z"F4dVa|گz*K=ϸ:eihxA8y-⳹F#;\ ?1k_Cn:;?~Lf)"uʀ&LY h>YzvW)0!I r$;,I6͗P mJ {5| L'-*Z͕2U-8;TyUtTLN5,LJ [`|jgo;O.uko7T 0ոZ(\vRnMlTE^`a{No !X#X# c5Eg11q z{e.'sB,V:|B)tBhk > CGAVQyp ׵!ZyR}';ީ"J*Ӈ[ZkC%N`qY W1bՒ[VQ6j4 b5DIB(fF!t!p*6Q6pMSfL4 } 8Occ4v`n+ZL/ =ilbDWH0?!1U|.'UZ du!֕MU=%F@4!8?P8Cm"p#5AQѩN.Y'}b.CwDXi x]|%X.{3'K+;\2#iTo EG3:51`]{=M 9u}o^_! QQn3M Ff`X׹)C=44ILw+m[޵O NJFn`HNR4 U!YDv%%k?!n,6tV~P%T2C5uzx!צ_!M$Q9V0 VIpLt B`EEptZՄ='sTT|%X%_hDN*wBmtL>b6v\6@THJhV3SVtjZ 95܂/O=צ8mOzsꭚFuHZ5iP-mP7`^`eIFG#ID,s2 x BAл%t a?!_5f(MccؗNuFk `'"·fXq P>sE_tw2h]A;1 *Z+<?Ę-ӋGv!0#v Ow:MJjlԝ$1KjƣqR\U쟨g'-$&4xo"inLm`e+W\'p#Ք3r ϩAEUؾwQ7 Úᗁ#YEDn2g%{_HUK6 H-gMuȆ//ϽZ53T!"{""Ҫ_eZ+8ӑ%N$vl`XUdK'1b14Zy WL!Ya!_LyTk0dYP ;MpҜ?OEPeض֭YE=eD!h?ρvG D/2ܿMoh MTy{!D+@< X Rr=mǔ ;ZtWG)8֠۰ZJuYg[+%q,=KlI™ +h.aXƱR'C/fēPsv^ s*Mx{0m+~trM6ʕ' z ]'@" e\bt&GaGWB+WBx)鸹8bU;[Z=> fvOSf0ͭR3S#L1ifSsSVʹ1XNf\iZ̉f:bmzrBrlOL;%+t񷮵pR7l[&-\GLm| n"F+Pkih0RwQyW\k5X=+vd/}5F6՛o-2F٢VNBkj ,wO9B 9[P[$b*\UCgT1ghL:VCF;zKr |iqdDž 'Bwa6<lHrhKJFD^D;҇C L* A `,ËpPyamF;q vO.]l__~"QY5epTS1N٤\DTY{ǒ@)4q,cNTNsQkcxqA.4ZPj |S8_fI Pq@?Cu5]H0g?&p`FU8„ ZIpy-!',jsqCa5al+ҩkJ麂N"L&XRLDNΥ):[%h`6Z:u4SÈZda.3{wpn09fۧ6bv0c~1& ެ,=tFAJr' bRy 9>4h~I*=w;S?*{ vxx.~\ *_lt+1{:]D8ۨ nޚϬrRG"b05 5ƙrv{Ѡٿ"9N5qݨQOajaC8x%~yFq9AVI 7حĶ. CܡV~kc{L[-xU{_ݍ\ina;?NҜ}A%B=*l@LJ3aϔRnϵrj%M_q-;3M쓕up"|\Wg=5(R6{Gxy<|su@R) һqU?z ^_b,VഐMx؇< ƃz\\θP4cpŕFFVy=g[EGm*k8*_4k+]X:x,,yrr:*kMRad QMd^owG|Ms̠uhu{m:NpQ*KI} ͜5fp7볛Wwzܕ09a (ONb?T*&@V'MzWjX%2gx{vJ ?dQ& jWw+/Qh}mR%eV*JB se}!_X,ƶFÝ~?7L*U=KeȖ,zn+Bs:"8R뤨yE>g 6bi TnC]5]6L\NŴ-"4ݼ6:-\TummoWq[7E#cTQus|Xإ8-FJOц/jG<gߤRj$P9CZ.M>$0sX)K+BOfR7$`ԊlH0Љ]ҫۋp0t7-?a,oXf%r|@,%K`nƭQv敼ύ|{|lj]zSʊI:DHA&!X^_Sd9B4l#3u{0Zq{=mz3P "=9:ʕ8vGFW زnG hN"=^ԍ LUWy;L`YfakxL`߻x|39ng}G۬I":gV7ۏojnGmN_Ft{o${XtƕF8h ڗc'W&h죣><|O 0 mr ^בoNҙ9ZkoQ)ΎBd|2&NϽrmLx9|M[]gޞDpD*Gmuh5/5u08ǽ^p6Y! bc&3rV)nvh^cNDT[V;=Ob{V7zK>?ͫǀ$& B!he6y?HiFg9E5K|i:l޽}Bz+/jI[-ǃM& .  D}*1\~Vg?uFΈ*ܨci{otr""Ej#=7pDRN ݯyWBLjWq Z/VEEB5WTp4% >sI.w&>0<{m%AX[?4dbV#8_ěUIuc(19z-#U:>&-r/Ψb";qw<Fgf"_?{ "U!O4oŸ>soׇ4y|#n' &V{#C_ηX"AFGk߷A?P5wsRh>.|;'$ ,6UYAҍxb;m>ivU2x"1}#ݹGl\}Ih1JoЩirUVךuxtN܁r` 4.^o+jX3l_l+ `>*SbU>ik[ A~?hcyзkbޥ!_k{۾1={j&w],6ØZvNJS;7e+ŝvaYl#B<'+nvU܉[有_4.E!x `0 \ x4R=+{2}[)5?7&-tqWM+H0|ӤLiAhL!󝞊"V]~2Դ;p&W}.R㾶/Q+ߌ@e)GhpB9 n{ {yܣ OzF f/'A't_L zhpz3[6;ҙ< 7Nj)~м/?N W W7FLQyy:;)2^<)DyQ&R?5C4_ɐii?M=i{={:p8[8t "4N}ඨ{9TmEoÉ*]fgx3Okph6ó5+D7yzZ7vH9mc+~gg89!
    Enjoying the preview?
    Page 1 of 1